SCHEMBL7598660

SCHEMBL7598660

CN(CCO)Cc1cc(NC(=N)c2cccs2)ccc1OC1CCCC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 7/20 0.44
PRMT1 Q99873 7/20 0.44
QRFPR Q96P65 3/20 0.43
PDE4B Q07343 1/20 0.37
POLB P06746 1/20 0.36
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 4/20 0.35
HTT P42858 1/20 0.35
C5AR1 P21730 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7971729 0.86 QRFPR (0.47) QRFPRKMT2AALDH1A1HTTNPSR1
SCHEMBL7568582 0.86 QRFPR (0.46) QRFPRPDE4BPOLBKMT2AALDH1A1
SCHEMBL7600914 0.85 QRFPR (0.39) CARM1PRMT1QRFPRKMT2AALDH1A1
Hydrochloric Acid SCHEMBL7598799 0.85 QRFPR (0.46) QRFPRKMT2AALDH1A1HTTNPSR1
SCHEMBL7598787 0.83 KMT2A (0.39) QRFPRPOLBKMT2AALDH1A1KDM4E
SCHEMBL7565602 0.83 QRFPR (0.46) CARM1PRMT1QRFPRPDE4BPOLB
SCHEMBL7973639 0.83 QRFPR (0.46) QRFPRPDE4BPOLBKMT2AALDH1A1
SCHEMBL7597196 0.83 ATM (0.39) QRFPRKMT2AALDH1A1NPSR1KDM4E
Hydrochloric Acid SCHEMBL7566301 0.82 QRFPR (0.46) CARM1PRMT1QRFPRPDE4BPOLB
Hydrochloric Acid SCHEMBL7562290 0.82 QRFPR (0.45) QRFPRPDE4BPOLBKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020137750-A1 Amidine derivatives which are inhibitors of nitric oxide synthase ASTRAZENECA AB (SE) 2002-09-26 US claimed
WO-2001046171-A1 AMIDINE DERIVATIVES WHICH ARE INHIBITORS OF NITRIC OXIDE SYNTHASE ASTRAZENECA AB (SE) 2001-06-28 WO claimed
US-20020137750-A1 Amidine derivatives which are inhibitors of nitric oxide synthase ASTRAZENECA AB (SE) 2002-09-26 US disclosed
WO-2001046171-A1 AMIDINE DERIVATIVES WHICH ARE INHIBITORS OF NITRIC OXIDE SYNTHASE ASTRAZENECA AB (SE) 2001-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020137750-A1 Amidine derivatives which are inhibitors of nitric oxide synthase NOS1, NOS2, NOS3 CARM1 360/4885PRMT1 12/4885QRFPR 1455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.